Get the Stockscreener App
0.87
3.33%
-0.03
After Hours:
.87
Akari Therapeutics Plc Adr Stock (AKTX) Forecast
The Akari Therapeutics Plc Adr (AKTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5069, representing a -41.74% decrease from the current price of $0.87. The highest analyst price target is $0.6504, and the lowest is $0.3633.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AKTX Price Target
Average 0.7318
(-15.88% Downside)
Is Akari Therapeutics Plc Adr (AKTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.41 | Neutral |
| STOCH(9,6) | 4.6788 | Buy |
| STOCHRSI(14) | 5.0201 | Buy |
| MACD(12,26) | -0.0844 | Sell |
| ADX(14) | 16.03 | Neutral |
| William %R | -98.50 | Buy |
| CCI(14) | -89.75 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9772
Sell
|
0.9717
Sell
|
| MA20 |
1.0684
Sell
|
1.0439
Sell
|
| MA50 |
1.1286
Sell
|
1.21
Sell
|
| MA100 |
1.5678
Sell
|
1.5548
Sell
|
| MA200 |
2.3229
Sell
|
1.95
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, AKTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on AKTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.41 indicates that AKTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 4.6788 indicates that AKTX is oversold. This indicates that AKTX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.0201 indicates that AKTX is oversold. This suggests that AKTX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.03 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -89.75 indicates that AKTX is still oversold but not to an extreme extent.
Long-term AKTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Akari Therapeutics Plc Adr financial reports and earnings history, Akari Therapeutics Plc Adr (AKTX) stock could reach $0.8778 by 2030, $2.6144 by 2040 and $4.3102 by 2050. See the projected annual prices until 2050 of the Akari Therapeutics Plc Adr stock below:
- Akari Therapeutics Plc Adr (AKTX) is expected to reach an average price of $1.2905 in 2035, with a high prediction of $1.9616 and a low estimate of $1.1606. This indicates an $48.34% rise from the last recorded price of $0.87.
- Akari Therapeutics Plc Adr (AKTX) stock is projected to chart a bullish course in 2040, with an average price target of $2.6391, representing an $203.35% surge from its current level. The forecast ranges from a conservative $2.6546 to a sky-high $2.6144.
- Our analysts predict Akari Therapeutics Plc Adr (AKTX) to jump 302.55% by 2045, soaring from $3.4506 to an average price of $3.5022, potentially reaching $3.4497. While $3.4506 is the low estimate, the potential upside is significant.
- Akari Therapeutics Plc Adr (AKTX) stock is expected to climb by 2050, reaching an average of $4.3802, a $403.47% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.3102 and $4.1956, respectively, highlighting the market's uncertainty.
Akari Therapeutics Plc Adr Stock (AKTX) Year by Year Forecast
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2025
Akari Therapeutics Plc Adr Stock (AKTX) is expected to reach an average price of $0.7318 in 2025, with a high prediction of $1.4506 and a low estimate of $0.0131. This indicates an -15.88% fall from the last recorded price of $0.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.4504 | $0.3633 | $0.6504 | -48.23% |
| April, 2025 | $0.0772 | $0.0322 | $0.5828 | -91.12% |
| May, 2025 | $0.2218 | $0.0131 | $0.2617 | -74.51% |
| June, 2025 | $0.4111 | $0.2488 | $0.8064 | -52.74% |
| July, 2025 | $0.7129 | $0.3735 | $1.4506 | -18.05% |
| August, 2025 | $0.6524 | $0.6324 | $1.33 | -25.01% |
| September, 2025 | $0.5818 | $0.5318 | $0.8595 | -33.12% |
| October, 2025 | $0.2837 | $0.2437 | $0.7442 | -67.40% |
| November, 2025 | $0.4431 | $0.241 | $0.5277 | -49.07% |
| December, 2025 | $0.2149 | $0.2149 | $0.7003 | -75.30% |
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2026
The predicted value for Akari Therapeutics Plc Adr (AKTX) in 2026 is set at an average of $1.5536. Estimates vary from a peak of $2.9675 to a trough of $0.1396, indicating an +78.57% surge from the present price of $0.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.2944 | $0.1396 | $0.4196 | -66.16% |
| February, 2026 | $0.6938 | $0.2492 | $0.9415 | -20.25% |
| March, 2026 | $1.9333 | $0.5098 | $1.9333 | +122.22% |
| April, 2026 | $2.6351 | $1.138 | $2.6551 | +202.88% |
| May, 2026 | $1.8045 | $1.3723 | $2.9675 | +107.42% |
| June, 2026 | $1.184 | $1.0693 | $1.8969 | +36.09% |
| July, 2026 | $0.6558 | $0.5358 | $1.9764 | -24.62% |
| August, 2026 | $0.5753 | $0.5053 | $0.7782 | -33.88% |
| September, 2026 | $0.4771 | $0.4071 | $0.6476 | -45.16% |
| October, 2026 | $0.5065 | $0.3742 | $0.5494 | -41.78% |
| November, 2026 | $0.666 | $0.3813 | $0.696 | -23.45% |
| December, 2026 | $0.4678 | $0.4578 | $0.7083 | -46.23% |
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Akari Therapeutics Plc Adr (AKTX) is $0.3386, with a high forecast of $0.6767 and a low forecast of $0.000509. This indicates an -61.08% decrease from the last price of $0.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.5473 | $0.3454 | $0.6767 | -37.10% |
| February, 2027 | $0.3767 | $0.3567 | $0.6196 | -56.70% |
| March, 2027 | $0.3985 | $0.2391 | $0.5638 | -54.19% |
| April, 2027 | $0.328 | $0.1932 | $0.5108 | -62.30% |
| May, 2027 | $0.2274 | $0.1727 | $0.3703 | -73.86% |
| June, 2027 | $0.2492 | $0.1045 | $0.4222 | -71.35% |
| July, 2027 | $0.1087 | $0.0137 | $0.2716 | -87.51% |
| August, 2027 | $0.0481 | $0.0334 | $0.1381 | -94.47% |
| September, 2027 | $0.12 | $0.000509 | $0.18 | -86.21% |
| October, 2027 | $0.0506 | $0.0397 | $0.1371 | -94.19% |
| November, 2027 | $0.0711 | $0.1082 | $0.0536 | -91.82% |
| December, 2027 | $0.4458 | $0.1083 | $0.5707 | -48.76% |
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2028
In 2028, Akari Therapeutics Plc Adr (AKTX) is projected to reach an average price of $0.3793, with a high projection of $0.7512 and a low estimate of $0.0075. This indicates an -56.40% fall from the last price of $0.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1051 | $0.0454 | $0.483 | -87.92% |
| February, 2028 | $0.3904 | $0.0075 | $0.3884 | -55.12% |
| March, 2028 | $0.5428 | $0.4682 | $0.5287 | -37.61% |
| April, 2028 | $0.432 | $0.4605 | $0.4861 | -50.34% |
| May, 2028 | $0.5373 | $0.4921 | $0.439 | -38.24% |
| June, 2028 | $0.478 | $0.5179 | $0.485 | -45.06% |
| July, 2028 | $0.4884 | $0.511 | $0.4638 | -43.86% |
| August, 2028 | $0.6665 | $0.5861 | $0.5976 | -23.39% |
| September, 2028 | $0.7374 | $0.7251 | $0.7172 | -15.25% |
| October, 2028 | $0.7602 | $0.7677 | $0.7372 | -12.62% |
| November, 2028 | $0.7638 | $0.753 | $0.7403 | -12.21% |
| December, 2028 | $0.7464 | $0.7581 | $0.7512 | -14.20% |
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2029
The 2029 price forecast for Akari Therapeutics Plc Adr Stock (AKTX) is $1.8012 on average, with a high prediction of $3.5089 and a low estimate of $0.0934. This represents an +107.03% increase from the previous price of $0.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.655 | $0.6945 | $0.7294 | -24.71% |
| February, 2029 | $2.6548 | $0.6604 | $3.0948 | +205.15% |
| March, 2029 | $2.7643 | $2.1119 | $3.0219 | +217.73% |
| April, 2029 | $2.7737 | $2.3614 | $3.5089 | +218.82% |
| May, 2029 | $2.5155 | $2.2355 | $3.1985 | +189.14% |
| June, 2029 | $2.375 | $1.9926 | $2.7079 | +172.99% |
| July, 2029 | $2.2745 | $1.8021 | $2.5174 | +161.43% |
| August, 2029 | $1.7863 | $1.6318 | $2.4568 | +105.32% |
| September, 2029 | $1.5156 | $1.2734 | $1.9086 | +74.21% |
| October, 2029 | $0.9975 | $0.8475 | $1.6228 | +14.66% |
| November, 2029 | $0.3632 | $0.2745 | $1.0898 | -58.25% |
| December, 2029 | $0.2117 | $0.0934 | $1.0582 | -75.67% |
Akari Therapeutics Plc Adr Stock (AKTX) Price Forecast for 2030
Akari Therapeutics Plc Adr Stock (AKTX) is expected to reach an average price of $0.7534 in 2030, with a high forecast of $1.335 and a low forecast of $0.1719. This signifies an -13.40% decrease from the last price of $0.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.713 | $0.1719 | $0.8778 | -18.05% |
| February, 2030 | $1.0541 | $0.8982 | $0.879 | +21.16% |
| March, 2030 | $1.0966 | $1.0346 | $1.0452 | +26.04% |
| April, 2030 | $0.8263 | $1.1457 | $0.901 | -5.03% |
| May, 2030 | $1.1576 | $1.0368 | $1.0726 | +33.06% |
| June, 2030 | $1.0837 | $1.1132 | $1.0637 | +24.57% |
| July, 2030 | $0.99 | $0.9943 | $0.9643 | +13.79% |
| August, 2030 | $1.0275 | $0.9606 | $0.8712 | +18.10% |
| September, 2030 | $0.5923 | $1.097 | $1.0217 | -31.92% |
| October, 2030 | $0.8532 | $0.9566 | $0.9434 | -1.94% |
| November, 2030 | $1.5197 | $0.9239 | $0.9497 | +74.68% |
| December, 2030 | $1.4408 | $1.3356 | $1.335 | +65.61% |
0.22%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):